NORTHAMPTON, MA / ACCESS Newswire / October 20, 2025 / Originally published on Aflac NewsroomIn a quiet corner of the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, somet ...

Sanofi's Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program If approved, Tzield would be the first disease-mo ...